Selective Expansion of Human Natural Killer Cells from Peripheral Blood Mononuclear Cells by the Cell Line, HFWT
- 1 March 2002
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 93 (3) , 313-319
- https://doi.org/10.1111/j.1349-7006.2002.tb02174.x
Abstract
An anchorage‐dependent Wilnis tumor cell line HFWT was found to stimulate selective and remarkable expansion of human natural killer (NK) cells from human peripheral blood mononuclear cells (PBMC). After PBMC of healthy donors were cultured on irradiated HFWT cells for 10–21 days, the lymphocytes expanded 58‐ to 401‐fold. This NK cell expansion required direct contact of PBMC with live, but not fixed, HFWT cells. The PBMC from an end‐stage brain tumor patient also expanded 156‐fold, whereas those cultured with irradiated NK‐sensitive K562 grew only 30.5‐fold. CD16+CD56+ NK cells accounted for more than 70% of the population expanded on HFWT cells. No essential difference in expression of NK receptors was observed in the expanded NK cells on HFWT and K562 and without feeder cells. The expanded NK cells killed not only fresh HFWT cells but, unexpectedly, also MHC class I‐expressing autologous brain tumor cells at an effector/target ratio of 4 for 24 h. These results will contribute to the development of a large‐scale preparation method for human NK cells, which will aid studies of NK cell biology and possible treatment of brain tumors.Keywords
This publication has 33 references indexed in Scilit:
- Reduction of End‐stage Malignant Glioma by Injection with Autologous Cytotoxic T LymphocytesJapanese Journal of Cancer Research, 1999
- NK CELL RECEPTORSAnnual Review of Immunology, 1998
- NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell ReceptorThe Journal of Experimental Medicine, 1997
- The enigma of the natural killer cellNature, 1995
- NKG2‐C is a receptor on human natural killer cells that recognizes structures on K562 target cellsEuropean Journal of Immunology, 1995
- P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.The Journal of Experimental Medicine, 1993
- Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assayCancer Immunology, Immunotherapy, 1992
- Carcinoembryonic proteins produced by Wilms' tumor cells in vitro and in vivoExperimental pathology, 1991
- Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cellsCellular Immunology, 1991
- A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562.The Journal of Experimental Medicine, 1985